Innovative Technologies and Approaches in Eye Disease Management and Refractive Surgery

Dear Colleagues,

In recent years, in the field of eye disease management and refractive surgery, innovative technologies and approaches have been introduced to medical devices. With this, the current Special Issue will feature reports on the latest information regarding eye surgery hardware and software. Specifically, it will focus on the following topics:

1. Improved vision with the introduction of multifocal intraocular lenses.

The use of multifocal intraocular lenses is becoming more common in cataract surgery. These lenses provide bifocal vision and improve visual convenience in patients' daily lives. However, they are not suitable for all patients, and individual adaptation tests and thorough consultation with doctors are important.

2. Progress in minimally invasive surgical techniques.

The introduction of the latest technologies, such as femtosecond lasers and 3D imaging systems, has improved the accuracy of surgery and reduced the burden on patients. These technologies also contribute to shortening surgery times and accelerating postoperative recovery.

3. Artificial intelligence (AI) in eye diseases.

AI has brought about great advances in diagnosis, treatment, and patient management in the field of ophthalmology. Its use is particularly advancing image diagnosis, the optimization of surgical plans, and the development of telemedicine; in the future it is expected to be applied to further improve accuracy and personalized medicine. However, AI is merely an auxiliary tool, and it is important to maximize its effectiveness by working together with ophthalmologists.

These technologies and approaches are improving the quality of eye care and contributing to improved visual health and quality of life for patients. We look forward to your contributions.

Dr. Hidenaga Kobashi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.